Myeloid-derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in chronic obstructive pulmonary disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 72, Issue 4, 2017, Pages 645-655

  Wright, A K A ^a,b   Newby, C ^b   Hartley, R A ^a   Mistry, V ^b   Gupta, S ^a   Berair, R ^b   Roach, K M ^b   Saunders, R ^b   Thornton, T ^a   Shelley, M ^a   Edwards, K ^a   Barker, B ^b   Brightling, C E ^a,b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

air trapping; fibrocytes; flow cytometry; ollagen type 1; path analysis model

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 1; MAJOR BASIC PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG FUNCTION; LUNG RESECTION; MALE; MIDDLE AGED; MYELOID-DERIVED SUPPRESSOR CELL; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; AGED; BLOOD; CASE CONTROL STUDY; CELL COUNT; CELL DIFFERENTIATION; FIBROBLAST; IMMUNOPHENOTYPING; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; X-RAY COMPUTED TOMOGRAPHY;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; CELL COUNT; CELL DIFFERENTIATION; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYELOID-DERIVED SUPPRESSOR CELLS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85000774184     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13061     Document Type: Article

References (43)

1. Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012;18:1711–1715.
2. Brightling CE, Bleecker ER, Panettieri RA Jr, Bafadhel M, She D, Ward CK et al. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med 2014;2:891–901.
3. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645–2653.
4. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011;365:1567–1575.
5. Hartley RA, Barker BL, Newby C, Pakkal M, Baldi S, Kajekar R et al. Relationship between lung function and quantitative computed tomographic parameters of airway remodeling, air trapping, and emphysema in patients with asthma and chronic obstructive pulmonary disease: a single-center study. J Allergy Clin Immunol 2016;137:1413–1422.
6. Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012;186:48–55.
7. Roderfeld M, Rath T, Voswinckel R, Dierkes C, Dietrich H, Zahner D et al. Bone marrow transplantation demonstrates medullar origin of CD34 + fibrocytes and ameliorates hepatic fibrosis in Abcb4−/− mice. Hepatology 2010;51:267–276.
8. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71–81.
9. Reich B, Schmidbauer K, Rodriguez Gomez M, Johannes Hermann F, Gobel N, Bruhl H et al. Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model. Kidney Int 2013;84:78–89.
10. Garcia-de-Alba C, Becerril C, Ruiz V, Gonzalez Y, Reyes S, Garcia-Alvarez J et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 2010;182:1144–1152.
11. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005;166:675–684.
12. Isgro M, Bianchetti L, Marini MA, Bellini A, Schmidt M, Mattoli S. The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma. Mucosal Immunol 2013;6:718–727.
13. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438–446.
14. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171:380–389.
15. Madala SK, Edukulla R, Schmidt S, Davidson C, Ikegami M, Hardie WD. Bone marrow-derived stromal cells are invasive and hyperproliferative and alter transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2014;50:777–786.
16. Kleaveland KR, Velikoff M, Yang J, Agarwal M, Rippe RA, Moore BB et al. Fibrocytes are not an essential source of type I collagen during lung fibrosis. J Immunol 2014;193:5229–5239.
17. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556–7562.
18. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007;353:104–108.
19. Bianchetti L, Marini MA, Isgro M, Bellini A, Schmidt M, Mattoli S. IL-33 promotes the migration and proliferation of circulating fibrocytes from patients with allergen-exacerbated asthma. Biochem Biophys Res Commun 2012;426:116–121.
20. Saunders R, Siddiqui S, Kaur D, Doe C, Sutcliffe A, Hollins F et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J Allergy Clin Immunol 2009;123:376–384.
21. Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt M, Mattoli S. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol 2012;5:140–149.
22. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN et al. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013;122:1105–1113.
23. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:588–594.
24. Trimble A, Gochuico BR, Markello TC, Fischer R, Gahl WA, Lee JK et al. Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. Am J Respir Crit Care Med 2014;190:1395–1401.
25. Wang CH, Huang CD, Lin HC, Lee KY, Lin SM, Liu CY et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008;178:583–591.
26. Wang CH, Huang CD, Lin HC, Huang TT, Lee KY, Lo YL et al. Increased activation of fibrocytes in patients with chronic obstructive asthma through an epidermal growth factor receptor-dependent pathway. J Allergy Clin Immunol 2012;129:1367–1376.
27. Nihlberg K, Larsen K, Hultgardh-Nilsson A, Malmstrom A, Bjermer L, Westergren-Thorsson G. Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir Res 2006;7:50.
28. Dupin I, Allard B, Ozier A, Maurat E, Ousova O, Delbrel E et al. Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway. J Allergy Clin Immunol 2015;137:1036–1042.
29. Mathai SK, Gulati M, Peng X, Russell TR, Shaw AC, Rubinowitz AN et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest 2010;90:812–823.
30. LaPar DJ, Burdick MD, Emaminia A, Harris DA, Strieter BA, Liu L et al. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann Thorac Surg 2011;92:470–477.
31. Fang L, Moore XL, Chan W, White DA, Chin-Dusting J and Dart AM. Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. Cardiovasc Res 2012;95:124–133.
32. Yeager ME, Nguyen CM, Belchenko DD, Colvin KL, Takatsuki S, Ivy DD et al. Circulating fibrocytes are increased in children and young adults with pulmonary hypertension. Eur Respir J 2012;39:104–111.
33. Fujiwara A, Kobayashi H, Masuya M, Maruyama M, Nakamura S, Ibata H et al. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. Respirology 2012;17:693–698.
34. Gilpin SE, Lung K, de Couto GT, Cypel M, Sato M, Singer LG et al. Bone marrow-derived progenitor cells in end-stage lung disease patients. BMC Pulm Med 2013;13:48.
35. From the global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2015. Available from: http://www.goldcopd.org/ (accessed 1 February 2016) [cited 1 August 2016].
36. Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 2016;7:12150.
37. Shipe R, Burdick MD, Strieter BA, Liu L, Shim YM, Sung SS et al. Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity. J Allergy Clin Immunol 2015;137:750–757.
38. Wright AK, Brightling CE. Circulating fibrocytes: will the real fibrocyte please stand up? J Allergy Clin Immunol 2016;137:1625–1626.
39. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:418–424.
40. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 2008;83:1323–1333.
41. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112:1029–1036.
42. Schouppe E, Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA. Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Immunobiology 2013;218:1385–1391.
43. Scrimini S, Pons J, Agusti A, Soriano JB, Cosio BG, Torrecilla JA et al. Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells. Respir Med 2013;107:1895–1903.